Remove 2023 Remove Clinic Remove Image Interpretation Remove Radiation Oncology
article thumbnail

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

Imaging Technology

from October 1 to 4, 2023. from October 1 to 4, 2023. PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Gauden , D.Phil.,

article thumbnail

Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Imaging Technology

Effective initial staging of prostate cancer, particularly with regards to the detection of metastatic disease, is critical to optimal clinical management of patients,” said Phillip H. Kuo, MD, Ph.D. , Departments of Medical Imaging, Medicine, and Biomedical Engineering. Gauden, D.Phil. Blue Earth Diagnostics received U.S.

article thumbnail

Backwards to the Future: The Return of the Radiology Oral Boards

Ben White

One of his tweets: #RGchat T1: the ABR certification exam is intended to test knowledge as it relates to competence, and critical thinking as it relates to image interpretation. It is not meant to represent a comprehensive review of clinical content. If it’s not a PACS, then it’s probably not a good test.

Radiology 130